go back

Ranibizumab (Susvimo) Sustained-Release Implant

New York rates for HCPCS C9093

Injection, ranibizumab, via sustained release intravitreal implant (Susvimo), 0.1 mg

Rates data updated July 2026.

Facilitymedian $78 · 10th–90th $66$810%20%40%10th90th$78Professionalmedian $78 · 10th–90th $66$810%50%10th90th$78

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$66.07
Median
$77.62
Typical High
$81.28
Aetna
Setting
Professional
Modifier
Global
Typical Low
$66.07
Median
$77.62
Typical High
$81.28